Drug
Who makes ultramicrosize griseofulvin?
4 companies list ultramicrosize griseofulvin as a human prescription drug. Forms: tablet; tablet, coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing ultramicrosize griseofulvin
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Sandoz Industrial Products S.AAustria | tablet, coated | ANDAANDA202805 | 2 | 5 |
| Sigmapharm Laboratories, LLCUnited States | tablet | ANDAANDA202545 | 2 | 1 |
| Ayurax, LLC. | tablet | ANDAANDA061996 | 1 | 0 |
| Chartwell RX, LLC. | tablet | ANDAANDA061996 | 1 | 0 |
Enquiry
Common questions
- Who makes ultramicrosize griseofulvin?
- 4 companies list ultramicrosize griseofulvin as a human prescription drug in the openFDA NDC Directory, led by Sandoz Industrial Products S.A, Sigmapharm Laboratories, LLC, Ayurax, LLC., Chartwell RX, LLC.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic ultramicrosize griseofulvin?
- 4 companies list ultramicrosize griseofulvin under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.